LAUREN KOWALSKI: Open Payments
NPI 1245723295 · OAK RIDGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 28 payments from 16 companies in 2025. Trend: 2023 $990 · 2024 $1,365 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| Genmab U.S., Inc. | 2 | $104 |
| PFIZER INC. | 4 | $76 |
| ABBVIE INC. | 4 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| TAIHO ONCOLOGY, INC. | 1 | $22 |
Products named: Epkinly, KEYTRUDA, IBRANCE, OJJAARA, VRAYLAR, PYLARIFY, NINLARO, LONSURF.
Industry payments across NJ — which companies pay providers there.
